Failing to prioritize a campaign promise when a party has substantial congressional power is evidence of political cynicism.

It is fair evidence of a priority gap and invites accountability. It does not, without more, prove that fundraising was the reason.

Trump's fulfillment of his judicial pledge proves his position was principled rather than transactional coalition politics.

Promise-keeping shows execution, not private conviction. A politician can make and keep a transactional promise; the internal motive remains unknowable from performance alone.

Competing priorities and confidence in then-existing Supreme Court precedent are more plausible explanations for Obama's inaction than a fundraising conspiracy.

Those explanations fit the public record without requiring hidden coordination. They do not excuse the strategic mistake of leaving a vulnerable right uncodified.

Trump privately supported abortion rights and adopted the opposite judicial program only to win evangelical votes.

The coalition incentive is obvious, but Trump's private conviction cannot be established from the transcript. Jason correctly attacks motive speculation and then commits a milder version of the same error.

Democratic leaders intentionally withheld achievable rights legislation because unresolved rights generated more donations.

The accusation needs direct evidence of motive. Strategic neglect, competing priorities, institutional constraints, and overconfidence in precedent can explain the same conduct without deliberate sabotage.

If Schumer failed to advance the marriage bill, that would prove the fundraising theory.

Even the proposed test was too strong because floor time, amendments, and vote certainty could matter. In any event, the prediction failed when the Senate passed the bill.

A durable tax advantage will influence a fab's valuation and investment decision more effectively than a one-time capital grant.

Durable after-tax cash flow matters, but it does not follow that grants are ineffective. A large upfront grant can change project NPV and absorb construction or ramp risk that later tax benefits do not address.

Past buybacks show that chipmakers could have funded strategically desired U.S. fabs without public capital.

Buybacks invite scrutiny, but they do not prove a marginal U.S. fab would clear a board's hurdle rate against cheaper foreign alternatives. The policy problem was the location-specific cost and security gap, not simply whether firms had ever held cash.

A sufficiently cheap and long-dated loan can make domestic fab construction attractive without direct grants.

It can help a financeable project, but it may not close persistent construction, labor, utility, and operating-cost gaps. The eventual program's heavier reliance on direct awards suggests policymakers did not think debt alone was enough.

Warrants or similar upside-sharing would improve the taxpayer bargain.

Upside participation can compensate taxpayers for taking company-specific risk, provided the terms do not discourage participation or confuse security goals with portfolio management.

Tax incentives are sufficient to induce the strategically desired domestic capacity without large direct grants.

The 25% investment credit was important, but the enacted program layered it with direct awards and loans. Hindsight supports tax incentives as one leg of the solution, not a demonstrated substitute for the other legs.

Direct fab incentives are essentially corporate welfare even when tied to national-security capacity.

That label skips the mechanism. Milestone-based awards can purchase a domestic supply-chain externality that no single firm captures, though they still require clawbacks, audits, and careful project selection.

The national-security value of domestic capacity is large enough to justify direct public contribution to fab construction.

Semiconductor concentration creates a real supply and security externality. Direct support can be justified when it is conditional, competitively allocated, and sized to the verified funding gap.

Milestone-based public capital can unlock projects that a rational private board would otherwise reject.

That is precisely how the later program was structured, with disbursement linked to construction, technology, production, and commercial milestones. Full success still depends on projects completing and operating competitively.

Public-market repricing would continue propagating backward through private growth and early-stage rounds.

That mechanism played out through slower dealmaking, more down rounds, and a difficult exit environment. Chamath was directionally early rather than wrong.

Waiting six months would reliably deliver better risk-adjusted seed investments than deploying in mid-2022.

Aggregate seed prices softened only modestly in 2022, and company quality is not observable from market averages. The correct answer depends on access, selection, reserves, and the investor's ability to fund follow-ons.

A frozen public exit market makes nearly all new private investment unattractive.

That is too broad for seed, where exits are many years away and new companies can be built around the new cost environment. It is much stronger advice for expensive late-stage rounds dependent on near-term public comparables.

Downturns select for more cost-conscious founders and can improve the quality of seed opportunities.

Tighter capital can reward focus and reduce waste, but it does not automatically improve every founder or guarantee favorable terms. Selection still matters more than the macro slogan.

Doubling the number of seed deals was the right response to the 2022 reset.

The claim is portfolio-specific and still lacks mature cash-return evidence. A higher pace works only if underwriting quality, ownership, reserves, and follow-on support are preserved.

Legacy overvaluation is largely irrelevant to a five-person seed company with real revenue discipline.

It matters less at entry, but it still affects future fundraising, customer budgets, acquisition markets, and the availability of Series A capital.

The move from $1 million to $5 million ARR eliminates enough risk to justify paying roughly twice the valuation.

Crossing that range can validate repeatability, sales capacity, and retention, making a higher price rational. The exact tradeoff varies by company and does not reduce macro or financing risk to zero.

In a reset, shifting later offers better risk-adjusted returns than competing at seed.

It is a coherent strategy, not a market law. Seed offers more ownership and upside; later entry offers more evidence. Returns depend on access, pricing, and selection.